Bill Burns
Board of Directors
okairos
Italy
Biography
Bill also serves on the boards of Genentech, Chugai, Masters Pharmaceuticals, Biotie Therapies and Shire. He is also the chairman of the Health Innovation Challenge Fund Joint Funding Committee at the Wellcome Trust. Previously, Bill held various executive positions during his 23 years at Roche, ultimately as Chief Executive Officer of the pharmaceuticals division. He remains a board member at Roche. Bill has extensive experience of international pharmaceuticals and of reshaping organisations including mergers and acquisitions. During his time with Roche, he had significant involvement in the privatisation of Genentech, the integration of Boehringer Mannheim and the negotiations that resulted in Roche becoming a majority owner of Chugai in Japan.
Research Interest
business
